The Latest

• 

  J&J’s recent medtech buys help to prop up devices unit

  Johnson & Johnson’s medtech acquisitions over the past year have fueled growth for its cardiovascular group, offsetting challenges in businesses like orthopedics and surgery.

  Medical Devices

• 

  FTC increases premerger reporting requirements over provider objections

  Companies will be required to disclose more information about minority investors and past M&A activity. Provider groups said the new requirements would be burdensome for hospitals.

  Legal

• 

  Hologic to buy Gynesonics for $350M to acquire fibroid system

  Gynesonics’ transcervical system uses ultrasound guidance and radiofrequency energy to ablate fibroids without the need for an incision.

  Medical Devices

• 

  Medtronic to evaluate Affera in ventricular tachycardia

  The FDA approved an early feasibility study of Medtronic’s Affera mapping and ablation system and Sphere-9 catheter in patients with ventricular tachycardia, an abnormal heart rhythm.

  Medical Devices

• 

  The Medtech Conference

  4 trends to watch at Advamed’s The Medtech Conference

  As medtech companies, experts and regulators gather in Toronto, FDA leadership changes and the upcoming U.S. presidential election loom over the industry.

  Medical Devices

• 

  J&J, Abbott and Intuitive kick off latest medtech earnings season

  From pulsed field ablation to diabetes tech and surgical robots, the updates will provide an early look at how key medtech markets performed last quarter.

  Medical Devices

• 

  Digital health deal count declines in Q3, but check sizes stabilize: Rock Health

  Startups notched 110 deals in the third quarter, compared with 133 in the second quarter. But average deal size held steady, suggesting investors are making “fewer, more focused bets,” according to the consultancy firm.

  Digital Health

• 

  Fresenius Medical Care increasing IV, dialysis solutions production to alleviate shortages

  B. Braun and Fresenius Medical Care said they will make more crucial products as the U.S. faces shortages following Hurricane Helene’s damage to a Baxter manufacturing facility.

  Medical Devices

• 

  Abbott enrolls pivotal PFA study 4 months ahead of schedule

  The company reported the enrollment milestone alongside news that it received clearance to sell its Advisor HD Grid X Mapping Catheter and started a trial of its Tactiflex Duo Ablation Catheter.

  Clinical Trials

• 

  Solventum names Egeland as chief medical officer

  Ryan Egeland, former CEO and co-founder of Crossfire Medical, rounds out the leadership team for the 3M spinoff.

  Medical Devices

• 

  Baxter ups IV fluid allocations amid supply shortages

  As hospitals around the U.S. report IV fluid shortages, Baxter has increased supply allocations for direct customers and distributors. It plans on returning to 90% to 100% allocation of certain supplies by the end of 2024.

  Medical Devices

• 

  CMR Surgical CEO Bose steps down

  Massimiliano Colella, who joined the surgical robotics firm in late 2023, was named interim CEO.

  Medical Devices

• 

  Shiratronics raises $66M for trial of neuromodulation migraine device

  The funding will support the trial, premarket approval application and initial commercial launch of a system that could interrupt or change the transmission of pain signals to the brain.

  Medical Devices

• 

  Deep Dive

  The number of AI medical devices has spiked in the past decade

  The FDA has authorized nearly 1,000 medical devices with artificial intelligence features as companies including GE Healthcare and Siemens Healthineers build out their AI efforts.

  Digital Health

• 

  Procept secures FDA approval to study surgical robot in prostate cancer

  The trial will compare the therapy to radical prostatectomy and could unlock a market that analysts value at $500 million.

  Clinical Trials

• 

  AHA asks Biden administration for relief amid IV fluid shortage from Hurricane Helene

  Hospitals have been contending with shortages of the life-saving supplies after Hurricane Helene damaged Baxter's manufacturing plant in North Carolina, according to the American Hospital Association.

  Medical Devices

• 

  Baxter says no structural damage at North Carolina site hit by Hurricane Helene

  The facility also has access to water and power. Baxter expects to share production plans over the next two weeks.

  Medical Devices

• 

  Mercury Medical recalls emergency resuscitators

  Healthcare professionals use the devices to provide newborns and infants with emergency breathing support.

  Medical Devices